Various types of cancers require a different approach for the isolation and analysis of genes from the tumor. Such tests can be uncomfortable, costly, and inaccessible in a number of clinics owing to the lack of specialists that perform them. To overcome such difficulties, companies are designing and launching non invasive genetic tests for detecting, monitoring or predicting the onset of cancer.
In a recent development, Trovagene announced successful development of its first molecular diagnostic test capable of detecting KRAS mutations from a urine specimen. Similarly, Exact Sciences developed a new noninvasive test for colorectal cancer screening.
With their evident benefits, companies are trying to cash in on new non invasive tests. This interest in non invasive tests will continue to fuel the growth of the IVD market, which will grow with a CAGR of around 7% during 2013-2018. In our study, “In-Vitro Diagnostics Market Outlook 2018”, each region’s current and future outlook to 2018 has been discussed. Further, each market has been broken down into eight distinct clinical segmentations and their current and future outlook to 2018 has been analyzed to provide a thorough opportunity assessment.
Besides, the report has delved into the business dynamics of the major players of the market. To provide a thorough understanding of the company’s business model, company’s current and historical financials have been analyzed. Moreover, each company’s strengths and weaknesses along with their recent industrial activities have also been assessed. This will help the reader to gain a deeper insight into the current competitive landscape and position its company accordingly.
The report provides a thorough research and rational analysis of the current status and expected position of the global IVD market. The analysis of the emerging sectors and key players in the market provides a holistic view to the reader. Explaining some of the constraints faced by the industry, the study also covers the emerging trends which would have a positive impact on the market growth. Overall, the report contains key actionable insights that will help the reader to gain a deeper knowledge of the industry, identify opportunities and design suitable business strategies.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM679.htm
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.